Moving Beyond the NAMs vs. Animals Narrative in Pharmaceutical Development
As part of an effort to reframe the prevailing narrative of NAMs as a replacement for animals towards one of
Scientific Perspectives
Scientific Perspectives
Scientific Perspectives, Uncategorized
Safety considerations for cereblon-recruiting targeted protein degraders
Aclairo’s Ron Wange and the HESI Targeted Protein Degrader Safety Group recently published a review of key safety issues with